Journal article

Cochlear pericytes are capable of reversibly decreasing capillary diameter in vivo after tumor necrosis factor exposure

M Bertlich, F Ihler, BG Weiss, S Freytag, M Strupp, M Canis

Otology and Neurotology | LIPPINCOTT WILLIAMS & WILKINS | Published : 2017

Abstract

Objective: The aim of this work was to evaluate the effect of tumor necrosis factor (TNF) and its neutralization with etanercept on the capability of cochlear pericytes to alter capillary diameter in the stria vascularis. Methods: Twelve Dunkin-Hartley Guinea pigs were randomly assigned to one of three groups. Each group was treated either with placebo and then placebo, TNF and then placebo, or TNF and then etanercept. Cochlear pericytes were visualized using diaminofluorescein-2-diacetate and intravasal blood flow by fluorescein-dextrane. Vessel diameter at sites of pericyte somas and downstream controls were quantified by specialized software. Values were obtained before treatment, after f..

View full abstract

University of Melbourne Researchers

Grants


Funding Acknowledgements

[ "Prof. M.S. declares to have received funds in return for consulting services to Abott, Pierre-Fabre, and Biogen Idec, as well as having received funds for the preparation of scientific training for Abbott, Biogen Idec, CSC, Henning Pharma, and GSK.", "This study was supported by a grant by the Deutsche Forschungsgemeinschaft to Professor M.C. under the grant code CA629/2-1." ]